LiqBio biomedical company limited
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
LiqBio Biomedical employs its flagship instrument CytoExplore to directly analyse and isolate rare cells from blood samples, thereby demonstrating the company’s technological strength in cancer detection, personalized medicine and new drug development.
Founded Year
2021
Unified Business No.
91096216
Status
Active
Number of Employees
0
Total Paid-in
Capital
146,250,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
The company is committed to the research and development of high-end medical analysis instrument. Independent research and development technology in Taiwan and cross-field technicians integrating molecular biology, clinical, electromechanical, optoelectro
